Atezolizumab Plus Bevacizumab Combined With Locoregional Therapies in Unresectable Hepatocellular Carcinoma (ISMIO-001)
Clinical trial NCT07204327 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07204327
- Sponsor
- Zhongda Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-28
- Primary completion
- 2025-10-31
- Enrollment
- 1136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.